Product Categories
| Country: | China |
|---|---|
| Tel: | 0316-2883536 |
| Mobile: | 19333636468 |
| E-mail: | 573487203@qq.com |
| QQ: | 2885506126 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Ticagrelor Impurity 69 | C10H8F2O2 | 220352-36-3 | Details |
| Ticagrelor Impurity 68 | C10H9F2NO | 1006376-62-0 | Details |
| Ticagrelor Impurity 66 | C23H28F2N6O4S | 2056269-94-2 | Details |
| Ticagrelor Impurity 78 | C20H27NO7 | 866551-95-3 | Details |
| Ticagrelor Impurity 80 | C10H19NO4 | 2165881-71-8 | Details |
| Ticagrelor Impurity 79 | C7H9Cl2N3S | 145783-15-9 | Details |
| Ticagrelor Impurity 76 | C8H12N2O2S | 39067-34-0 | Details |
| Ticagrelor Impurity 73 | C9H10ClF2N | 1156491-10-9 | Details |
| Ticagrelor Impurity 81 | C6H7ClIN | 14338-32-0 | Details |
| Ticagrelor Impurity 85 | C26H32F2N6O4S | 2236556-48-0 | Details |
| Ticagrelor Impurity 77 | C17H17F2NO3 | 376608-71-8 | Details |
| Ticagrelor Impurity 72 | C23H27F2N7O5S | 2476859-55-7 | Details |
| Ticagrelor Impurity 75 | C5H6N2O2S | 1979-98-2 | Details |
| Ticagrelor Impurity 71 | C14H25NO10 | 376608-65-0 | Details |
| Thiamine EP Impurity D | C12H16N4O2S | 490-82-4 | Details |
| Cilnidipine Impurity A | C27H26N2O7 | 146845-34-3 | Details |
| Thiamine hydrochloride Impurity 1 | C7H10N4O | 1886-34-6 | Details |
| 6-Aminouracil | C4H5N3O2 | 873-83-6 | Details |
| Istradefylline Impurity 10 | C6H8N4O3 | 1019659-02-9 | Details |
| Thiamine EP Impurity A | C12H16N4O4S2 | 2380-61-2 | Details |
| Ozagrel Impurity 1 | C12H14O3 | 530145-11-0 | Details |
| Ticagrelor Impurity 83 | C26H32F2N6O4S | 2435586-17-5 | Details |
| 4-Methylcinnamic acid | C10H10O2 | 1866-39-3 | Details |
| 2,4(1H,3H)-Pyrimidinedione, 6-amino-3-ethyl- | C6H9N3O2 | 21237-00-3 | Details |
| Ticagrelor Impurity 82 | C34H50ClN9O8S2 | 2205903-75-7 | Details |
| 2,4(1H,3H)-Pyrimidinedione, 6-amino-1,3-diethyl-5-nitro- | C8H12N4O4 | 146946-10-3 | Details |
| Thiamine EP Impurity C | C12H17Cl3N4S | 7275-24-3 | Details |
| METHYL 4-METHYLCINNAMATE | C11H12O2 | 20754-20-5 | Details |
| Ticagrelor Impurity 84 | 2446590-77-6 | Details |
| Ticagrelor Impurity 86 | C9H11ClFN | 1314324-00-9 | Details |
| 2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid | C12H10N2O3 | 80047-38-7 | Details |
| Thiothiamine;Thiamine EP Impurity E | C12H16N4OS2 | 299-35-4 | Details |
| MILRINONE RELATED COMPOUND A (50 MG) (1,6-DIHYDRO-2-METHYL-6-OXO(3,4'-BIPYRIDINE)-5-CAR-BOXAMIDE) | C12H11N3O2 | 80047-24-1 | Details |
| Milrinone Impurity 3 | C7H6N4O2 | 1089899-00-2 | Details |
| Vortioxetine Impurity 4 | C18H22N2S | 1293489-77-6 | Details |
| Vortioxetine Impurity 20 | C18H22N2O2S | 1639263-80-1 | Details |
| Vortioxetine Impurity 21 | C14H15NS | 33264-60-7 | Details |
| Cyanamide, N,N-dicyano- | C3HN2Na | 1449007-47-9 | Details |
| 1-[2-[(2,4-diMethylphenyl)sulfinyl]phenyl]- Piperazine | C18H22N2OS | 1429908-35-9 | Details |
| Vortioxetine Impurity 1 | C17H20N2S | 1293489-71-0 | Details |
| C40H48N8O8 | 702697-27-6 | Details |
| 1-Piperazinecarboxaldehyde, 4-[2-[(2,4-dimethylphenyl)sulfinyl]phenyl]- | C19H22N2O2S | 2425618-48-8 | Details |
| Thiamine EP Impurity G | C14H20Cl2N4O2S | 1037-29-2 | Details |
| 1-[2-[(2,6-diMethylphenyl)thio]phenyl]- Piperazine | C18H22N2S | 508233-76-9 | Details |
| 1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine | C18H22N2S | 1293489-74-3 | Details |
| Vortioxetine Impurity 18 | C14H13NO2S | 27758-55-0 | Details |
| Thiamine EP Impurity H | C14H20N4O3S2 | 89285-03-0 | Details |
| Vortioxetine Impurity 2 | C17H20N2S | 1293489-69-6 | Details |
| Caffeic acid | C9H8O4 | 331-39-5 | Details |
| C19H22N2OS | 2135576-73-5 | Details |
| Vortioxetine Imp.E | C18H22N2S | 508233-77-0 | Details |
| Vortioxetine impurity S | C18H22N2S | 1815608-51-5 | Details |
| Milrinone Impurity 15 | C12H9N3O2 | 156033-07-7 | Details |
| 2-Ethyl Milrinone | C13H11N3O | 78504-63-9 | Details |
| 1,3-Diazepane-2,4,6-trione | C5H6N2O3 | 338756-68-6 | Details |
| 1,3-DIETHYL-5-NITROSO-6-AMINOURACIL | C8H12N4O3 | 89073-60-9 | Details |
| Itraphylline impuritie7 | C18H20N4O4 | 155272-03-0 | Details |
| Vortioxetine Impurity D | C18H22N2S | 508233-75-8 | Details |
| Vortioxetine Impurity 22 | C38H44N4OS2 | 2476761-84-7 | Details |
| Vortioxetine Impurity 3 | C17H20N2S | 508233-82-7 | Details |
| 4-ethoxy-3-(4-pyridyl)-3-buten-2-one | C11H13NO2 | 88349-61-5 | Details |
| Vortioxetine Impurity 26 | 2137793-92-9 | Details |
| Cetirizine Impurity 40 | C24H31ClN2O4 | 2705552-48-1 | Details |
| Cetirizine USP Related Compound A | C23H29ClN2O3 | 246870-46-2 | Details |
| Cetirizine Impurity K | C24H31ClN2O5 | 1243652-36-9 | Details |
| Enzalutamide Impurity I | C21H18F4N4O3S | 2030242-21-6 | Details |
| 4-(DIPHENYLMETHYL)-1-PIPERAZINEETHANOL DIHYDROCHLORIDE | C19H26Cl2N2O | 108983-83-1 | Details |
| Prasugrel EP Impurity E | C20H21ClFNO3S | 1056459-37-0 | Details |
| Dicyandiamide | C2H4N4 | 461-58-5 | Details |
| Oseltamivir phosphate | C16H31N2O8P | 204255-11-8 | Details |
| Vortioxetine Impurity 23 | C18H21N3OS | 2925447-38-5 | Details |
| Sodium sarcosinate | C3H8NNaO2 | 4316-73-8 | Details |
| Cetirizine IMpurity D | C30H28Cl2N2 | 346451-15-8 | Details |
| Hydroxyzine dihydrochloride | C21H29Cl3N2O2 | 2192-20-3 | Details |
| Prasugrel EP Impurity C | C20H20FNO3S | 1391194-50-5 | Details |
| 2-(4-((4-chlorophenyl)(phenyl)methyl) piperazin-1-yl)acetic acid dihydrochloride | C19H21ClN2O2 | 113740-61-7 | Details |
| Creatine | C4H9N3O2 | 57-00-1 | Details |
| 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-3-(1-ethylpropoxy)-5-[2-formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]-, ethyl ester, (4R,5S)-rel- | C22H32N2O6 | 2434599-55-8 | Details |
| Prasugrel Impurity G | C11H9FO2 | 1391054-37-7 | Details |
| Cetirizine EP Impurity B Ethyl Ester | C21H25ClN2O2 | 19178-83-7 | Details |
| 4-[(4-Chlorophenyl)phenylmethyl]-1-piperazineethanol dihydrochloride | C19H25Cl3N2O | 164726-80-1 | Details |
| Prasugrel hydrochloride | C20H20FNO3S.ClH | 389574-19-0 | Details |
| Prasugrel Impurity I | C20H21NO3S | 1391194-45-8 | Details |
| Vortioxetine Impurity 22 | C14H13NO2S | 1631967-38-8 | Details |
| 5-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-5,6,7,7a-tetra hydrothieno[3,2-c]pyridin-2(4H)-one | C18H18FNO2S | 150322-38-6 | Details |
| 1-benzhydrylpiperazine dihydrochloride | C17H22Cl2N2 | 66090-75-3 | Details |
| Prasugrel Impurity 13 HCl | C18H19ClFNOS | 1618108-01-2 | Details |
| Enzalutamide Impurity O | C21H17F3N4O2S | 915087-16-0 | Details |
| OSELTAMIVIR ACID | C14H24N2O4 | 187227-45-8 | Details |
| Dibanzyloxy phosphatecreatinine | C18H20N3O4P | 19208-69-6 | Details |
| 1-METHYLHYDANTOIN | C4H6N2O2 | 616-04-6 | Details |
| N,N-DIMETHYL-GUANIDINE | C3H9N3 | 6145-42-2 | Details |
| disodiumN-(carboxylatomethyl)-N-methylglycinate | C5H9NO4.2Na | 71160-37-7 | Details |
| Cetirizine -EP-Imp-F; | C21H26N2O3 | 83881-54-3 | Details |
| Prasugrel EP Impurity B | C20H20FNO3S | 1391194-39-0 | Details |
| 1-Methylguanidine hydrochloride | C2H8ClN3 | 21770-81-0 | Details |
| Creatinine | C4H7N3O | 60-27-5 | Details |
| 4-N-Desacetyl-5-N-acetyl OseltaMivir | C16H28N2O4 | 956267-10-0 | Details |
| Cyanamide | CH2N2 | 420-04-2 | Details |
| Oxo Enzalutamide | C21H16F4N4O3 | 1242137-18-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 | ||||